Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225976496> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4225976496 endingPage "1462" @default.
- W4225976496 startingPage "1459" @default.
- W4225976496 abstract "Aim:To determine the 0.1 percent topical sodium diclofenac analgesic effect on the retina during laser photocoagulation. Study Design: Arandomized prospective control study. Place and Duration:In the Ophthalmology department of Hayatabad Medical complex Peshawar and Woman Medical and Dental College, Abbottabad for duration of six months from November 2020 to April 2021. Methods:The study included 90 people with 47 cases of proliferative diabetic retinopathy who had two sessions of pan-retinal photocoagulation (group A) as well as 43 people with non-proliferative diabetic retinopathy who received bilateral grid treatment (group B) (group B).sodium chloride 0.9% or Sodium diclofenac 0.1% topical drops were instilled 30–135 mints formerly to treatment with laser in a concealed fashion.When a patient had 2 sessions, the alternative medicine was administered in the second session. The visual analogue scale was castoff to measure the amount of pain immediately after the laser therapy (VAS). The findings were subjected to statistical analysis Results: In 84/90 sessions, patients in A grouptestifiedpain (93.3 percent). When 0.1 percent sodium diclofenac drops were instilled, the mean stated grade of pain was 47.8 percent, and when 0.9 percent sodium chloride drops were instilled, the mean reported degree of pain was 53.3 percent. Only 14/60 sessions (23.3 percent) of patients in group B reported pain, and pain levels varied from 10% to 60% depending on the kind of drops administered. There was no link between pain intensity and the time it took to go from applying the drops to laser therapy (30–135 minutes) or the average energy level utilized (100–500 mW) in either group. Conclusion:Pan-retinal photocoagulation should be performed after the administration of sodium diclofenac 0.1 percent, which is an excellent pain reliever." @default.
- W4225976496 created "2022-05-05" @default.
- W4225976496 creator A5012278873 @default.
- W4225976496 creator A5016161336 @default.
- W4225976496 creator A5051696350 @default.
- W4225976496 creator A5067738941 @default.
- W4225976496 creator A5080214224 @default.
- W4225976496 creator A5082172981 @default.
- W4225976496 date "2022-01-31" @default.
- W4225976496 modified "2023-09-29" @default.
- W4225976496 title "Topical Sodium Diclofenac during Pan-Retinal Photocoagulation in Patients with Proliferative Diabetic Retinopathy" @default.
- W4225976496 doi "https://doi.org/10.53350/pjmhs221611459" @default.
- W4225976496 hasPublicationYear "2022" @default.
- W4225976496 type Work @default.
- W4225976496 citedByCount "0" @default.
- W4225976496 crossrefType "journal-article" @default.
- W4225976496 hasAuthorship W4225976496A5012278873 @default.
- W4225976496 hasAuthorship W4225976496A5016161336 @default.
- W4225976496 hasAuthorship W4225976496A5051696350 @default.
- W4225976496 hasAuthorship W4225976496A5067738941 @default.
- W4225976496 hasAuthorship W4225976496A5080214224 @default.
- W4225976496 hasAuthorship W4225976496A5082172981 @default.
- W4225976496 hasBestOaLocation W42259764961 @default.
- W4225976496 hasConcept C118487528 @default.
- W4225976496 hasConcept C134018914 @default.
- W4225976496 hasConcept C141071460 @default.
- W4225976496 hasConcept C14184104 @default.
- W4225976496 hasConcept C2779826273 @default.
- W4225976496 hasConcept C2779829184 @default.
- W4225976496 hasConcept C2780820201 @default.
- W4225976496 hasConcept C2780827179 @default.
- W4225976496 hasConcept C2908765736 @default.
- W4225976496 hasConcept C42219234 @default.
- W4225976496 hasConcept C555293320 @default.
- W4225976496 hasConcept C71924100 @default.
- W4225976496 hasConcept C98274493 @default.
- W4225976496 hasConceptScore W4225976496C118487528 @default.
- W4225976496 hasConceptScore W4225976496C134018914 @default.
- W4225976496 hasConceptScore W4225976496C141071460 @default.
- W4225976496 hasConceptScore W4225976496C14184104 @default.
- W4225976496 hasConceptScore W4225976496C2779826273 @default.
- W4225976496 hasConceptScore W4225976496C2779829184 @default.
- W4225976496 hasConceptScore W4225976496C2780820201 @default.
- W4225976496 hasConceptScore W4225976496C2780827179 @default.
- W4225976496 hasConceptScore W4225976496C2908765736 @default.
- W4225976496 hasConceptScore W4225976496C42219234 @default.
- W4225976496 hasConceptScore W4225976496C555293320 @default.
- W4225976496 hasConceptScore W4225976496C71924100 @default.
- W4225976496 hasConceptScore W4225976496C98274493 @default.
- W4225976496 hasIssue "1" @default.
- W4225976496 hasLocation W42259764961 @default.
- W4225976496 hasOpenAccess W4225976496 @default.
- W4225976496 hasPrimaryLocation W42259764961 @default.
- W4225976496 hasRelatedWork W1782637624 @default.
- W4225976496 hasRelatedWork W1989512926 @default.
- W4225976496 hasRelatedWork W2016342886 @default.
- W4225976496 hasRelatedWork W2027514099 @default.
- W4225976496 hasRelatedWork W2030204375 @default.
- W4225976496 hasRelatedWork W2147579172 @default.
- W4225976496 hasRelatedWork W2177724967 @default.
- W4225976496 hasRelatedWork W2476685808 @default.
- W4225976496 hasRelatedWork W4280609662 @default.
- W4225976496 hasRelatedWork W4289398803 @default.
- W4225976496 hasVolume "16" @default.
- W4225976496 isParatext "false" @default.
- W4225976496 isRetracted "false" @default.
- W4225976496 workType "article" @default.